• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 convalescent plasma: Interim recommendations from the AABB.

作者信息

Cohn Claudia S, Estcourt Lise, Grossman Brenda J, Pagano Monica B, Allen Elizabeth S, Bloch Evan M, Casadevall Arturo, Devine Dana V, Dunbar Nancy M, Foroutan Farid, Gniadek Thomas J, Goel Ruchika, Gorlin Jed, Joyner Michael J, Metcalf Ryan A, Raval Jay S, Rice Todd W, Shaz Beth H, Vassallo Ralph R, Winters Jeffrey L, Beaudoin Gregory, Tobian Aaron A R

机构信息

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

NHS Blood and Transplant, Oxford, UK.

出版信息

Transfusion. 2021 Apr;61(4):1313-1323. doi: 10.1111/trf.16328. Epub 2021 Mar 7.

DOI:10.1111/trf.16328
PMID:33586160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8014606/
Abstract
摘要

相似文献

1
COVID-19 convalescent plasma: Interim recommendations from the AABB.新型冠状病毒肺炎康复者血浆：美国血库协会临时建议
Transfusion. 2021 Apr;61(4):1313-1323. doi: 10.1111/trf.16328. Epub 2021 Mar 7.
2
Convalescent plasma for COVID-19 - encouraging signals of efficacy.用于治疗新冠肺炎的康复期血浆——疗效的鼓舞人心信号。
Br J Haematol. 2021 Feb;192(4):681-682. doi: 10.1111/bjh.17270. Epub 2021 Feb 1.
3
Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan.康复期血浆作为苏丹2019冠状病毒病的一种治疗方式。
Transfus Apher Sci. 2020 Dec;59(6):102918. doi: 10.1016/j.transci.2020.102918. Epub 2020 Aug 27.
4
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.美国血库协会（AABB）临床实践指南：COVID-19 恢复期血浆。
Ann Intern Med. 2022 Sep;175(9):1310-1321. doi: 10.7326/M22-1079. Epub 2022 Aug 16.
5
Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.关于新冠康复患者捐献的恢复期血浆（CBP）的评论
Transfus Apher Sci. 2021 Jun;60(3):103108. doi: 10.1016/j.transci.2021.103108. Epub 2021 Mar 2.
6
High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples.高通量检测 SARS-CoV-2 刺突蛋白靶向抗体在纵向恢复期血浆样本中的存在。
Transfusion. 2021 May;61(5):1377-1382. doi: 10.1111/trf.16318. Epub 2021 Feb 18.
7
Convalescent plasma treatment of critically ill intensive care COVID-19 patients.恢复期血浆治疗危重症 COVID-19 患者的 ICU 治疗。
Transfusion. 2021 May;61(5):1394-1403. doi: 10.1111/trf.16392. Epub 2021 Apr 8.
8
Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics.新冠康复者血浆的应用经验为未来应对大流行提供了重要指导。
Transfusion. 2022 Mar;62(3):681-684. doi: 10.1111/trf.16810. Epub 2022 Jan 30.
9
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation.COVID-19 恢复期血浆疗法在造血干细胞移植后儿科患者中的应用。
Transfus Apher Sci. 2021 Feb;60(1):102983. doi: 10.1016/j.transci.2020.102983. Epub 2020 Nov 1.
10
Google Trends demonstrate public interest in COVID-19 convalescent plasma therapy.谷歌趋势显示了公众对新冠康复者血浆疗法的兴趣。
J Clin Apher. 2021 Jun;36(3):492-493. doi: 10.1002/jca.21862. Epub 2020 Dec 19.

引用本文的文献

1
Factors associated with the SARS-CoV-2 immunoglobulin-G titer levels in convalescent whole-blood donors: a Chinese cross-sectional study.与恢复期全血供者中 SARS-CoV-2 免疫球蛋白-G 滴度相关的因素：一项中国的横断面研究。
Sci Rep. 2024 Mar 13;14(1):6072. doi: 10.1038/s41598-024-56462-y.
2
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review.抗新冠病毒的高效价免疫血浆和免疫球蛋白：叙述性综述
Life (Basel). 2024 Feb 1;14(2):214. doi: 10.3390/life14020214.
3
Blood-derived product therapies for SARS-CoV-2 infection and long COVID.用于治疗SARS-CoV-2感染和长期新冠的血液衍生产品疗法。
MedComm (2020). 2023 Nov 15;4(6):e426. doi: 10.1002/mco2.426. eCollection 2023 Dec.
4
Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise.退伍军人事务部冠状病毒研究与疗效研究-1（VA CURES-1）的设计：一项针对早期出现呼吸功能不全的住院COVID-19患者进行的双盲、随机、安慰剂对照试验，使用新冠康复者血浆。
Contemp Clin Trials Commun. 2023 Jul 17;35:101190. doi: 10.1016/j.conctc.2023.101190. eCollection 2023 Oct.
5
Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China.新冠肺炎恢复期全血献血者高 SARS-CoV-2 免疫球蛋白 G 滴度的预测因素：中国的一项横断面研究。
Front Immunol. 2023 Jun 14;14:1191479. doi: 10.3389/fimmu.2023.1191479. eCollection 2023.
6
Exercise and Experiments of Nature.《自然的锻炼与实验》
Compr Physiol. 2023 Jun 26;13(3):4879-4907. doi: 10.1002/cphy.c220027.
7
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19.自然灾害、人道主义紧急情况和大流行病期间的血液供应管理：从 COVID-19 中吸取的教训。
Expert Rev Hematol. 2023 Jul-Dec;16(7):501-514. doi: 10.1080/17474086.2023.2209716. Epub 2023 May 9.
8
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review.新冠疫情期间恢复期血浆疗法（CCP）的有效性：文献综述
J Blood Med. 2023 Feb 22;14:159-187. doi: 10.2147/JBM.S397722. eCollection 2023.
9
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center.美国一家学术医疗中心的 COVID-19 恢复期血浆项目评估。
PLoS One. 2022 Dec 8;17(12):e0277707. doi: 10.1371/journal.pone.0277707. eCollection 2022.
10
Use of convalescent plasma in pregnant women with early stage COVID-19 infection in a tertiary care hospital in Dubai, February to March 2021: a case series study.2021 年 2 月至 3 月，在迪拜一家三级保健医院，使用恢复期血浆治疗处于 COVID-19 感染早期阶段的孕妇：病例系列研究。
BMC Pregnancy Childbirth. 2022 Sep 25;22(1):730. doi: 10.1186/s12884-022-05043-w.

本文引用的文献

1
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.恢复期血浆抗体水平与新冠死亡风险。
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
2
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性：系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
3
(A Little) Clarity on Convalescent Plasma for Covid-19.关于新冠康复期血浆治疗的一点解读
N Engl J Med. 2021 Feb 18;384(7):666-668. doi: 10.1056/NEJMe2035678. Epub 2021 Jan 13.
4
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.早期高滴度血浆疗法预防老年人重症 COVID-19。
N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.
5
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.新冠肺炎重症肺炎患者恢复期血浆的随机临床试验。
N Engl J Med. 2021 Feb 18;384(7):619-629. doi: 10.1056/NEJMoa2031304. Epub 2020 Nov 24.
6
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG.在一大群2019冠状病毒病（COVID-19）患者中，早期输注含有高滴度抗严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白IgG的康复期血浆可显著降低死亡率。
Am J Pathol. 2021 Jan;191(1):90-107. doi: 10.1016/j.ajpath.2020.10.008. Epub 2020 Nov 4.
7
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
8
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).恢复期血浆治疗印度成人中度 COVID-19 的管理：开放标签 II 期多中心随机对照试验（PLACID 试验）。
BMJ. 2020 Oct 22;371:m3939. doi: 10.1136/bmj.m3939.
9
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.恢复期血浆治疗重症 COVID-19：一项倾向评分匹配对照研究。
Nat Med. 2020 Nov;26(11):1708-1713. doi: 10.1038/s41591-020-1088-9. Epub 2020 Sep 15.
10
The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq.康复期血浆疗法对治疗伊拉克巴格达医院呼吸监护病房中危重新冠肺炎患者的治疗潜力。
Infez Med. 2020 Sep 1;28(3):357-366.